logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Healthcare Services
Filter

Healthcare Services

Categories

Sectors

Locations

Exchange

医疗保健精选——Aptorum Group公开募集900万美元资金,辉瑞与中国基石药业达成交易

Healthcare Roundup – Aptorum Group raises $9M in public offering, Pfizer inks deal with CStone

Sep 30, 2020

Life Science

Healthcare Roundup – Analysts move to sidelines on Inovio on delay in pivotal COVID-19 vaccine study, JD.com’s Health-Care Business to go public in Hong Kong

Sep 29, 2020

Life Science

中美AI药研企业晶泰科技获3亿美元融资

AI Drug R&D Startup XtalPi Announces Over 300 Million Series C Investment Led by SoftBank Vision Fund, PICC Capital, and Morningside

Sep 28, 2020

Life Science

中国益方生物获1.47亿美元投资,投资者为何充满信心?

Investors Prove Confidence in InventisBio with $147 Million

Sep 28, 2020

Life Science

医疗保健精选——强生COVID-19疫苗在早期试验中表现出强烈的免疫反应,吉利德filgotinib在欧洲获批用于治疗类风湿性关节炎

Healthcare Roundup – J&J COVID-19 vaccine sees strong immune response in early trial, Gilead and Galapagos’ filgotinib OK’d in Europe for rheumatoid arthritis

Sep 26, 2020

Life Science

医疗保健精选——白宫可能出手干预过于严格的FDA疫苗法规;Novavax启动COVID-19候选疫苗的关键研究

Healthcare Roundup – White House may overrule tightening of FDA vaccine rules, Novavax initiates pivotal study of COVID-19 vaccine candidate

Sep 25, 2020

Life Science

医疗保健精选——NeuroRx申请RLF-100治疗新冠肺炎的紧急使用授权,阿斯利康在美国的新冠疫苗后期研究依然搁置

Healthcare Roundup – NeuroRx requests emergency use of RLF-100 in COVID-19, AstraZeneca’s late-stage U.S. study of COVID-19 vaccine still on hold

Sep 24, 2020

Life Science

医疗保健精选——FDA将制定严格标准,疫苗或无法在美国大选前获批;Adial开始销售新冠试剂

Healthcare Roundup – Stricter FDA standards make COVID-19 vaccine approval unlikely before election day, Adial commence sale of COVID-19 test kits

Sep 23, 2020

Life Science

医疗保健精选——联邦医疗保险目前不能报销COVID-19疫苗费用,梯瓦在美国推出两款治疗哮喘的数字呼吸机

Healthcare Roundup – Medicare coverage of COVID-19 vaccine not there, Teva launches two digital inhalers in U.S. for asthma

Sep 22, 2020

Life Science

医疗保健精选——Moderna预计将生产2000万剂COVID-19疫苗,Agenus的PD-1抑制剂显示治疗宫颈癌的积极疗效

Healthcare Roundup – Moderna expects to produce 20M doses of COVID-19 vaccine, Agenus PD-1 inhibitor shows positive effect

Sep 18, 2020

Life Science

医疗保健精选——Moderna与Vertex Pharma扩大合作,Moderna与Chiesi Group合作

Healthcare Roundup – Moderna expands cystic fibrosis partnership with Vertex Pharma, Moderna teams up with Chiesi Group

Sep 16, 2020

Life Science

医疗保健精选——Alexion Pharma股价上涨7%;首席执行官评论COVID-19疫苗计划,Moderna上涨5%

Healthcare Roundup – Alexion Pharma up 7%, Moderna up 5% after CEO comments on COVID-19 vaccine program

Sep 15, 2020

Life Science

医疗保健精选——阿斯利康在英国恢复COVID-19疫苗试验,Seattle Genetics与默克公司合作治疗癌症

Healthcare Roundup – AstraZeneca COVID-19 vaccine trials resume in U.K., Seattle Genetics teams up with Merck in cancer

Sep 15, 2020

Life Science

医疗保健精选——国家药监局批准再鼎医药的则乐补充新药上市申请,FDA批准葛兰素的Trelegy Ellipta用于治疗哮喘

Healthcare Roundup – Zai Lab’s Zejula OK’d in China, FDA OKs expanded use of Glaxo’s Trelegy Ellipta in asthma

Sep 10, 2020

Life Science

医疗保健精选——COVID-19疫苗开发股齐涨,阿斯利康COVID-19疫苗试验将于下周恢复

Healthcare Roundup- COVID-19 vaccine developers rally, Trial of AstraZeneca COVID-19 vaccine may resume next week

Sep 10, 2020

Life Science

医疗保健精选——美联储运送雅培的售价仅5美元的COVID-19快检试剂,罗氏将在获得CE认证的国家启动新冠病毒抗原检测

Healthcare Roundup – Feds to ship Abbott’s $5 rapid COVID-19 tests, Roche to launch rapid coronavirus antigen test in CE Mark countries

Sep 2, 2020

Life Science

医疗保健精选——阿斯利康将“遵循科学”开发COVID-19疫苗,FDA批准紧急使用T2 Biosystems的COVID-19试剂

Healthcare Roundup – AstraZeneca to “follow the science” in development of COVID-19 vaccine, FDA OKs emergency use of T2 Biosystems COVID-19 test

Aug 31, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Postpones Filing of Interim Financial Statements and MD&A Due to COVID-19 Related Delays

Aug 28, 2020

Life Science

  • ‹‹ Previous
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada